Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Introducing personalized health for the family: the experience of a single hospital system.

Huddleston KL, Klein E, Fuller A, Jo G, Lawrence G, Haga SB.

Pharmacogenomics. 2017 Nov;18(17):1589-1594. doi: 10.2217/pgs-2017-0112. Epub 2017 Oct 24.

PMID:
29061078
2.

Considering the Benefits and Risks of Research Participants' Access to Sequence Data.

Haga SB, Friedman B, Richard G.

Genet Test Mol Biomarkers. 2017 Oct 18. doi: 10.1089/gtmb.2017.0143. [Epub ahead of print]

PMID:
29045186
3.

Informational Quest.

Haga SB.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001860. doi: 10.1161/CIRCGENETICS.117.001860. No abstract available.

PMID:
28779018
4.

Educating patients and providers through comprehensive pharmacogenetic test reports.

Haga SB.

Pharmacogenomics. 2017 Jul;18(11):1047-1050. doi: 10.2217/pgs-2017-0088. Epub 2017 Jul 7. No abstract available.

PMID:
28686141
5.

Development and Initial Assessment of a Patient Education Video about Pharmacogenetics.

Mills R, Ensinger M, Callanan N, Haga SB.

J Pers Med. 2017 May 25;7(2). pii: E4. doi: 10.3390/jpm7020004.

6.

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.

Haga SB, Mills R, Moaddeb J, Allen LaPointe N, Cho A, Ginsburg GS.

Pharmacogenomics. 2017 Mar;18(4):359-367. doi: 10.2217/pgs-2016-0177. Epub 2017 Feb 22.

PMID:
28244812
7.

Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.

Haga SB, Moaddeb J, Mills R, Voora D.

Pharmacogenomics. 2017 Mar;18(4):327-335. doi: 10.2217/pgs-2016-0175. Epub 2017 Feb 22.

PMID:
28244804
8.

Rationale and design of the SLCO1B1 genotype guided statin therapy trial.

Singh K, Peyser B, Trujillo G, Milazzo N, Savard D, Haga SB, Musty M, Voora D.

Pharmacogenomics. 2016 Nov 3. [Epub ahead of print] No abstract available.

PMID:
27807988
9.

Patient experiences with pharmacogenetic testing in a primary care setting.

Haga SB, Mills R, Moaddeb J, Allen Lapointe N, Cho A, Ginsburg GS.

Pharmacogenomics. 2016 Oct;17(15):1629-1636. Epub 2016 Sep 20.

10.

A review of consent practices and perspectives for pharmacogenetic testing.

Haga SB, Mills R.

Pharmacogenomics. 2016 Sep;17(14):1595-605. doi: 10.2217/pgs-2016-0039. Epub 2016 Aug 17. Review.

11.

Evaluation of a pharmacogenetic educational toolkit for community pharmacists.

Haga SB, Mills R, Moaddeb J.

Pharmacogenomics. 2016 Sep;17(14):1491-502. doi: 10.2217/pgs-2016-0002. Epub 2016 Aug 17.

12.

Challenges of development and implementation of point of care pharmacogenetic testing.

Haga SB.

Expert Rev Mol Diagn. 2016 Sep;16(9):949-60. doi: 10.1080/14737159.2016.1211934. Epub 2016 Jul 22. Review.

PMID:
27402403
13.

Considerations of pharmacogenetic testing in children.

Haga SB, Solomon BD.

Pharmacogenomics. 2016 Jun;17(9):975-7. doi: 10.2217/pgs-2016-0073. Epub 2016 Jun 1. No abstract available.

14.

Proposal for a pharmacogenetics certificate program for pharmacists.

Haga SB, Moaddeb J.

Pharmacogenomics. 2016 Apr;17(6):535-9. doi: 10.2217/pgs.16.11. Epub 2016 Mar 29. No abstract available.

15.

Incorporation of pharmacogenetic testing into medication therapy management.

Haga SB, Moaddeb J, Mills R, Patel M, Kraus W, Allen LaPointe NM.

Pharmacogenomics. 2015 Nov;16(17):1931-41. doi: 10.2217/pgs.15.124. Epub 2015 Nov 10.

PMID:
26555559
16.

Community pharmacists' experience with pharmacogenetic testing.

Moaddeb J, Mills R, Haga SB.

J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):587-94. doi: 10.1331/JAPhA.2015.15017.

PMID:
26409205
17.

Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.

Arora S, Haverfield E, Richard G, Haga SB, Mills R.

J Genet Couns. 2016 Apr;25(2):337-43. doi: 10.1007/s10897-015-9876-y. Epub 2015 Aug 19.

PMID:
26283062
18.

Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention.

Gallagher P, King HA, Haga SB, Orlando LA, Joy SV, Trujillo GM, Scott WM, Bembe M, Creighton DL, Cho AH, Ginsburg GS, Vorderstrasse A.

J Health Commun. 2015;20(6):728-35. doi: 10.1080/10810730.2015.1018563. Epub 2015 Apr 6.

PMID:
25844569
19.

Potential use of auxiliary labels to promote patient awareness of pharmacogenetic testing.

Haga SB, Moaddeb J.

Pharmacogenomics. 2015;16(4):299-301. doi: 10.2217/pgs.14.184. No abstract available.

20.

Challenges to integrating pharmacogenetic testing into medication therapy management.

Haga SB, Allen LaPointe NM, Moaddeb J.

J Manag Care Spec Pharm. 2015 Apr;21(4):346-52. Review.

Supplemental Content

Loading ...
Support Center